Epidemiology and clinical significance of carbapenemases in Australia: a narrative review

AT Aslan, DL Paterson - Internal Medicine Journal, 2024 - Wiley Online Library
Carbapenemase‐producing gram‐negative bacteria (CP‐GNB) infections threaten public
health with high mortality, morbidity and treatment costs. Although frequencies remain low in …

Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40 Acinetobacter baumannii Clone in a Tertiary Hospital in Northern Spain

M Aranzamendi, K Xanthopoulou… - International Journal of …, 2024 - mdpi.com
Infections caused by carbapenem-resistant Acinetobacter baumannii are a global threat
causing a high number of fatal infections. This microorganism can also easily acquire …

Co-occurrence of blaNDM-1 and blaOXA-23 in carbapenemase-producing Acinetobacter baumannii belonging to high-risk lineages isolated from burn patients …

A Raddaoui, A Mabrouk, Y Chebbi… - Journal of Applied …, 2024 - academic.oup.com
Abstract Aims Carbapenem-resistant Acinetobacter baumannii (CR-Ab) is an important
cause of infections in burn patients. This study aimed to characterize the antimicrobial …

A 19-year longitudinal study to characterize carbapenem-nonsusceptible Acinetobacter isolated from patients with bloodstream infections and the contribution of …

PK Chen, YT Lee, CY Liu, TTD Thuy, K Anh… - Journal of Microbiology …, 2024 - Elsevier
Background This study aimed to characterize carbapenem-nonsusceptible Acinetobacter
(CNSA) isolated from patients with bacteremia from 1997 to 2015. Methods A total of 173 …

Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii ST2 in Oceania: a multicountry cohort study

SC Baleivanualala, L Isaia, SV Devi… - The Lancet Regional …, 2023 - thelancet.com
Summary Background Carbapenem resistant Acinetobacter baumannii (CRAb) is
categorised by the World Health Organization (WHO) as a pathogen of critical concern …

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β …

A Santerre Henriksen, K Jeannot, A Oliver… - Microbiology …, 2024 - Am Soc Microbiol
Carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major
threats and have few approved therapeutic options. Non-‍fermenting Gram-negative isolates …

The molecular detection of carbapenem markers with a two-levels amplification screening protocol: epidemiological and resistome insights

M Calvo, G Migliorisi, G Maugeri, D Bongiorno… - Frontiers in …, 2024 - frontiersin.org
Objectives Carbapenem-resistance is a challenging healthcare concern and require specific
stewardship programs. Monitoring workflows include the identification from surveillance …

A panel of genotypically and phenotypically diverse clinical Acinetobacter baumannii strains for novel antibiotic development

C Sun, D Zhou, J He, H Liu, Y Fu, Z Zhou… - Microbiology …, 2024 - Am Soc Microbiol
Acinetobacter baumannii is one of the most important pathogens worldwide. The intrinsic
and acquired resistance of A. baumannii, coupled with the slow pace of novel antimicrobial …

Antibiotic resistances of Pseudomonas aeruginosa and Acinetobacter baumannii in urine cultures: experience in a hospital of Southeast Spain

H Requena‐Cabello, E Rodríguez‐Guerrero… - APMIS, 2024 - Wiley Online Library
The objectives of this study were to perform a systematic review of publications between
2010 and 2021 on the antibiotic resistance of Pseudomonas aeruginosa and Acinetobacter …

Reliability of a Screening Method Using Antibiotic Disks to Detect Carbapenemases in Glucose‐Nonfermenting Gram‐Negative Microorganisms From Clinical …

I Hernández‐Chico… - Journal of Clinical …, 2024 - Wiley Online Library
Background Infections by glucose‐nonfermenting gram‐negative bacilli (NFGNB) pose a
major public health problem due to multiresistance to beta‐lactam antibiotics, especially …